Phase 2 randomized study of bortezomib-melphalan-prednisone with or without siltuximab (anti-IL-6) in multiple myeloma. San-Miguel, J., Blade, J., Shpilberg, O., Grosicki, S., Maloisel, F., Min, C., Polo Zarzuela, M., Robak, T., Prasad, S. V. S. S., Tee Goh, Y., Laubach, J., Spencer, A., Mateos, M., Palumbo, A., Puchalski, T., Reddy, M., Uhlar, C., Qin, X., van de Velde, H., Xie, H., & Orlowski, R. Z. Blood, 123(26):4136–4142, June, 2014. ![Phase 2 randomized study of bortezomib-melphalan-prednisone with or without siltuximab (anti-IL-6) in multiple myeloma [link]](https://bibbase.org/img/filetypes/link.svg "link")
Paper doi bibtex @article{san-miguel_phase_2014-1,
title = {Phase 2 randomized study of bortezomib-melphalan-prednisone with or without siltuximab (anti-{IL}-6) in multiple myeloma},
volume = {123},
issn = {0006-4971, 1528-0020},
url = {http://www.bloodjournal.org/cgi/doi/10.1182/blood-2013-12-546374},
doi = {10.1182/blood-2013-12-546374},
language = {en},
number = {26},
urldate = {2019-06-24},
journal = {Blood},
author = {San-Miguel, J. and Blade, J. and Shpilberg, O. and Grosicki, S. and Maloisel, F. and Min, C.-K. and Polo Zarzuela, M. and Robak, T. and Prasad, S. V. S. S. and Tee Goh, Y. and Laubach, J. and Spencer, A. and Mateos, M.-V. and Palumbo, A. and Puchalski, T. and Reddy, M. and Uhlar, C. and Qin, X. and van de Velde, H. and Xie, H. and Orlowski, R. Z.},
month = jun,
year = {2014},
pages = {4136--4142},
file = {San-Miguel et al. - 2014 - Phase 2 randomized study of bortezomib-melphalan-p.pdf:/Users/neil.hawkins/Zotero/storage/R4JGF3J4/San-Miguel et al. - 2014 - Phase 2 randomized study of bortezomib-melphalan-p.pdf:application/pdf},
}
Downloads: 0
{"_id":"iB65sLLR2c77JGcCt","bibbaseid":"sanmiguel-blade-shpilberg-grosicki-maloisel-min-polozarzuela-robak-etal-phase2randomizedstudyofbortezomibmelphalanprednisonewithorwithoutsiltuximabantiil6inmultiplemyeloma-2014","author_short":["San-Miguel, J.","Blade, J.","Shpilberg, O.","Grosicki, S.","Maloisel, F.","Min, C.","Polo Zarzuela, M.","Robak, T.","Prasad, S. V. S. S.","Tee Goh, Y.","Laubach, J.","Spencer, A.","Mateos, M.","Palumbo, A.","Puchalski, T.","Reddy, M.","Uhlar, C.","Qin, X.","van de Velde, H.","Xie, H.","Orlowski, R. Z."],"bibdata":{"bibtype":"article","type":"article","title":"Phase 2 randomized study of bortezomib-melphalan-prednisone with or without siltuximab (anti-IL-6) in multiple myeloma","volume":"123","issn":"0006-4971, 1528-0020","url":"http://www.bloodjournal.org/cgi/doi/10.1182/blood-2013-12-546374","doi":"10.1182/blood-2013-12-546374","language":"en","number":"26","urldate":"2019-06-24","journal":"Blood","author":[{"propositions":[],"lastnames":["San-Miguel"],"firstnames":["J."],"suffixes":[]},{"propositions":[],"lastnames":["Blade"],"firstnames":["J."],"suffixes":[]},{"propositions":[],"lastnames":["Shpilberg"],"firstnames":["O."],"suffixes":[]},{"propositions":[],"lastnames":["Grosicki"],"firstnames":["S."],"suffixes":[]},{"propositions":[],"lastnames":["Maloisel"],"firstnames":["F."],"suffixes":[]},{"propositions":[],"lastnames":["Min"],"firstnames":["C.-K."],"suffixes":[]},{"propositions":[],"lastnames":["Polo","Zarzuela"],"firstnames":["M."],"suffixes":[]},{"propositions":[],"lastnames":["Robak"],"firstnames":["T."],"suffixes":[]},{"propositions":[],"lastnames":["Prasad"],"firstnames":["S.","V.","S.","S."],"suffixes":[]},{"propositions":[],"lastnames":["Tee","Goh"],"firstnames":["Y."],"suffixes":[]},{"propositions":[],"lastnames":["Laubach"],"firstnames":["J."],"suffixes":[]},{"propositions":[],"lastnames":["Spencer"],"firstnames":["A."],"suffixes":[]},{"propositions":[],"lastnames":["Mateos"],"firstnames":["M.-V."],"suffixes":[]},{"propositions":[],"lastnames":["Palumbo"],"firstnames":["A."],"suffixes":[]},{"propositions":[],"lastnames":["Puchalski"],"firstnames":["T."],"suffixes":[]},{"propositions":[],"lastnames":["Reddy"],"firstnames":["M."],"suffixes":[]},{"propositions":[],"lastnames":["Uhlar"],"firstnames":["C."],"suffixes":[]},{"propositions":[],"lastnames":["Qin"],"firstnames":["X."],"suffixes":[]},{"propositions":["van","de"],"lastnames":["Velde"],"firstnames":["H."],"suffixes":[]},{"propositions":[],"lastnames":["Xie"],"firstnames":["H."],"suffixes":[]},{"propositions":[],"lastnames":["Orlowski"],"firstnames":["R.","Z."],"suffixes":[]}],"month":"June","year":"2014","pages":"4136–4142","file":"San-Miguel et al. - 2014 - Phase 2 randomized study of bortezomib-melphalan-p.pdf:/Users/neil.hawkins/Zotero/storage/R4JGF3J4/San-Miguel et al. - 2014 - Phase 2 randomized study of bortezomib-melphalan-p.pdf:application/pdf","bibtex":"@article{san-miguel_phase_2014-1,\n\ttitle = {Phase 2 randomized study of bortezomib-melphalan-prednisone with or without siltuximab (anti-{IL}-6) in multiple myeloma},\n\tvolume = {123},\n\tissn = {0006-4971, 1528-0020},\n\turl = {http://www.bloodjournal.org/cgi/doi/10.1182/blood-2013-12-546374},\n\tdoi = {10.1182/blood-2013-12-546374},\n\tlanguage = {en},\n\tnumber = {26},\n\turldate = {2019-06-24},\n\tjournal = {Blood},\n\tauthor = {San-Miguel, J. and Blade, J. and Shpilberg, O. and Grosicki, S. and Maloisel, F. and Min, C.-K. and Polo Zarzuela, M. and Robak, T. and Prasad, S. V. S. S. and Tee Goh, Y. and Laubach, J. and Spencer, A. and Mateos, M.-V. and Palumbo, A. and Puchalski, T. and Reddy, M. and Uhlar, C. and Qin, X. and van de Velde, H. and Xie, H. and Orlowski, R. Z.},\n\tmonth = jun,\n\tyear = {2014},\n\tpages = {4136--4142},\n\tfile = {San-Miguel et al. - 2014 - Phase 2 randomized study of bortezomib-melphalan-p.pdf:/Users/neil.hawkins/Zotero/storage/R4JGF3J4/San-Miguel et al. - 2014 - Phase 2 randomized study of bortezomib-melphalan-p.pdf:application/pdf},\n}\n\n","author_short":["San-Miguel, J.","Blade, J.","Shpilberg, O.","Grosicki, S.","Maloisel, F.","Min, C.","Polo Zarzuela, M.","Robak, T.","Prasad, S. V. S. S.","Tee Goh, Y.","Laubach, J.","Spencer, A.","Mateos, M.","Palumbo, A.","Puchalski, T.","Reddy, M.","Uhlar, C.","Qin, X.","van de Velde, H.","Xie, H.","Orlowski, R. Z."],"bibbaseid":"sanmiguel-blade-shpilberg-grosicki-maloisel-min-polozarzuela-robak-etal-phase2randomizedstudyofbortezomibmelphalanprednisonewithorwithoutsiltuximabantiil6inmultiplemyeloma-2014","role":"author","urls":{"Paper":"http://www.bloodjournal.org/cgi/doi/10.1182/blood-2013-12-546374"},"metadata":{"authorlinks":{}}},"bibtype":"article","biburl":"https://bibbase.org/f/FfNE7kWA6pCvwcJZF/myPubs.bib","dataSources":["ZaHtWavQhcwZqKLNF","iRRNaRs6FkffgErta","v8uQmZsBpiqycmskv"],"keywords":[],"search_terms":["phase","randomized","study","bortezomib","melphalan","prednisone","without","siltuximab","anti","multiple","myeloma","san-miguel","blade","shpilberg","grosicki","maloisel","min","polo zarzuela","robak","prasad","tee goh","laubach","spencer","mateos","palumbo","puchalski","reddy","uhlar","qin","van de velde","xie","orlowski"],"title":"Phase 2 randomized study of bortezomib-melphalan-prednisone with or without siltuximab (anti-IL-6) in multiple myeloma","year":2014}